DEMÊNCIA EM DOENÇA DO NEURÔNIO MOTOR: REVISÃO DO PAPEL DA RM NO DIAGNÓSTICO

Rocha, Antonio José da; Nunes, Renato Hoffmann; Maia Jr., Antonio Carlos Martins

doi:10.1590/1980-57642015DN94000369

home Table of contents navigate_before previous current next navigate_next

Abstract (English)
Abstract (Portuguese)

Text (English)

Download PDF (English)

Abstract (English)
Abstract (Portuguese)
Text (English)
Download PDF (English) (abre em nova aba)

Whatsapp
BlueSky
Mastodon
Facebook
Mais

home Table of contents

Whatsapp
BlueSky
Mastodon
Facebook
Mais

Abstract (English)
Abstract (Portuguese)

Text (English)

Download PDF (English) (abre em nova aba)

Views & Reviews • Dement. neuropsychol. 9 (4) • Oct-Dec 2015 • https://doi.org/10.1590/1980-57642015DN94000369 linkcopiar

DEMÊNCIA EM DOENÇA DO NEURÔNIO MOTOR: REVISÃO DO PAPEL DA RM NO DIAGNÓSTICO

Autoria SCIMAGO INSTITUTIONS RANKINGS

As características clínicas sobreposta da doença do neurônio motor (DNM) e demência frontotemporal (DFT) compreendem um distinto ainda não totalmente compreendido, base neurológica síndrome de sobreposição clínico-patológico foi recentemente revisto. Aqui, apresentamos uma revisão das bases clínicas, patológicas e genética de DNM-DFT e o papel da ressonância magnética no diagnóstico STI. Ao fazê-lo, discutimos as técnicas atuais que retratam o envolvimento do trato corticoespinhal seletiva (TCS) e lobo temporal em DNM-DFT.

Palavras-chave:
demência frontotemporal; ressonância magnética; doença do neurônio motor; eslerose lateral amiotrófica; degeneração do lobo frontotemporal

Autoria

person Antonio José da Rocha

schoolPhD, Division of Neuroradiology - Santa Casa de Misericórdia de São Paulo, Brazil.Santa Casa de Misericórdia de São PauloBrazilBrazilPhD, Division of Neuroradiology - Santa Casa de Misericórdia de São Paulo, Brazil.schoolMD, Division of Neuroradiology - Fleury Medicina e Saúde (São Paulo - Brazil)Fleury Medicina e SaúdeBrazilSão Paulo, BrazilMD, Division of Neuroradiology - Fleury Medicina e Saúde (São Paulo - Brazil)

person Renato Hoffmann Nunes

person Antonio Carlos Martins Maia Jr.

.Antonio José da Rocha. Santa Casa de Misericordia de São Paulo / Serviço de Diagnostico por Imagem - Rua Dr. Cesário Motta Junior, 112 - 01221-020 São Paulo SP - Brazil. E-mail:
a.rocha@uol.com.br

Author contributions. Dr. Rocha was responsible for the study concept, critical revision of the manuscript and for imaging selection. Dr. Maia Jr and Dr. Nunes were responsible for the literature review and writing the manuscript

Disclosure: The authors report no conflits of interest

SCIMAGO INSTITUTIONS RANKINGS

PhD, Division of Neuroradiology - Santa Casa de Misericórdia de São Paulo, Brazil.Santa Casa de Misericórdia de São PauloBrazilBrazilPhD, Division of Neuroradiology - Santa Casa de Misericórdia de São Paulo, Brazil.

MD, Division of Neuroradiology - Fleury Medicina e Saúde (São Paulo - Brazil)Fleury Medicina e SaúdeBrazilSão Paulo, BrazilMD, Division of Neuroradiology - Fleury Medicina e Saúde (São Paulo - Brazil)

Figuras | Tabelas

Figuras (2)
Tabelas (2)

Thumbnail

Figure 1 A man of 42 years of age presented with UMN + LMN signs associated with dementia and language-speech abnormalities (his mother had died at 67 years old with a diagnosis of ALS-FTD). [A] Axial T1 MTC image showed an abnormally selective hyperintensity throughout the corticospinal tracts, predominantly on the left side, assuming a typical 'W-like appearance' crossing the corpus callosum (arrowheads). [B] Coronal FLAIR image depicted a marked atrophy in the left temporal pole with blurring of the grey/white matter differentiation (arrows). Note the abnormal hyperintensity in the left amygdala and hippocampus.

Thumbnail

Figure 2 A man of 61 years of age presented with a history of progressive non-fluent aphasia in the four months prior to admission. This was followed by an asymmetrical flaccid tetraparesis, hyperreflexia in all four limbs, which was associated with a bilateral Hoffmann sign, and fasciculation. [A] Axial T1 MTC image showed an abnormal hyperintensity involving the cortical and subcortical frontal areas including pre-central gyri and the remaining subcortical regions of the frontal lobes. [B-C] Axial and coronal FLAIR images depicted left temporal lobe atrophy with blurring of the grey/white matter differentiation (arrows). [D] Brain macroscopy confirmed atrophy in the left temporal lobe (arrow). Left hippocampus cortex showed neuronal loss as well as cytoplasmic, nuclear and extracellular UI inclusions, in addition to neuronal loss and astrogliosis (not shown).

Thumbnail

Table 1 A summary of genetic, clinical and brain histopathology data together with the possible target of mutations in ALS and/or FTD.²⁰ ⁸²

Thumbnail

Table 2 Defining cognitive and behavioural subtypes in ALS.⁸³

imageFigure 1 A man of 42 years of age presented with UMN + LMN signs associated with dementia and language-speech abnormalities (his mother had died at 67 years old with a diagnosis of ALS-FTD). [A] Axial T1 MTC image showed an abnormally selective hyperintensity throughout the corticospinal tracts, predominantly on the left side, assuming a typical 'W-like appearance' crossing the corpus callosum (arrowheads). [B] Coronal FLAIR image depicted a marked atrophy in the left temporal pole with blurring of the grey/white matter differentiation (arrows). Note the abnormal hyperintensity in the left amygdala and hippocampus. open_in_new

imageFigure 2 A man of 61 years of age presented with a history of progressive non-fluent aphasia in the four months prior to admission. This was followed by an asymmetrical flaccid tetraparesis, hyperreflexia in all four limbs, which was associated with a bilateral Hoffmann sign, and fasciculation. [A] Axial T1 MTC image showed an abnormal hyperintensity involving the cortical and subcortical frontal areas including pre-central gyri and the remaining subcortical regions of the frontal lobes. [B-C] Axial and coronal FLAIR images depicted left temporal lobe atrophy with blurring of the grey/white matter differentiation (arrows). [D] Brain macroscopy confirmed atrophy in the left temporal lobe (arrow). Left hippocampus cortex showed neuronal loss as well as cytoplasmic, nuclear and extracellular UI inclusions, in addition to neuronal loss and astrogliosis (not shown). open_in_new

table_chartTable 1 A summary of genetic, clinical and brain histopathology data together with the possible target of mutations in ALS and/or FTD.²⁰ ⁸²

In general, the inclusions are ubiquitin-positive and contain the ubiquitin binding protein p62. (ALS: Amyotrophic Lateral Sclerosis; FTD: Frontotemporal dementia; UMN: upper motor neuron; bvFTD= behavioural Frontotemporal dementia)

table_chartTable 2 Defining cognitive and behavioural subtypes in ALS.⁸³

ALS-FTD	ALS-bvFTD	ALS patient meeting either the Neary criteria or Hodge's criteria for FTD
ALS-PNFA	ALS patient meeting Neary criteria for PNFA
ALS-SD	ALS patient meeting Neary criteria for SD
Other forms	ALSbi	ALS patient meeting at least two non-overlapping supportive diagnostic features from either the Neary criteria or Hodge's criteria for FTD
ALSci	Evidence of cognitive impairment at or below the 5th percentile on at least two different tests of cognition that are sensitive to executive functioning
FTD-MND like	A neuropathological diagnosis with a primary frontotemporal lobar degeneration diagnosis with evidence of MND-type degeneration but insufficient to be classified as ALS
ALS dementia	ALS with dementia, not typical of FTD (ALS-Alzheimer, ALS-vascular dementia)
ALS-parkinsonian dementia complex	ALS concurrent with dementia and/or parkinsonianism occurring in hyperendemic foci of the Western Pacific

ALS: Amyotrophic Lateral Sclerosis; FTD: Frontotemporal Dementia; ALS-bvFTD: Amyotrophic Lateral Sclerosis and behavioural Frontotemporal Dementia; ALS-PNFA= Amyotrophic Lateral Sclerosis and Primary Non-fluent Aphasia; ALS-SD: Amyotrophic Lateral Sclerosis and Semantic Dementia; ALSbi: Amyotrophic Lateral Sclerosis with behavioural impairment; ALSci: Amyotrophic Lateral Sclerosis with cognitive impairment; MND: Motor Neuron Disease.

Como citar

linkcopiar

Ferramentas do artigo

PDFs
Metrics
Figuras e tabelas
Versions and translations
How to cite this article
Related articles

location_on

Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento R. Vergueiro, 1353 sl.1404 - Ed. Top Towers Offices, Torre Norte, São Paulo, SP, Brazil, CEP 04101-000, Tel.: +55 11 5084-9463 | +55 11 5083-3876 - São Paulo - SP - Brazil
E-mail: revistadementia@abneuro.org.br | demneuropsy@uol.com.br

rss_feed Stay informed of issues for this journal through your RSS reader

PDF version for download

PDF

English

Lista de links para artigos relacionados. Os links abrem em nova aba.

Google (abre em nova aba)
Google Scholar (abre em nova aba)

Versões e tradução automática

Escolha a versão original do texto ou utilize um serviço de tradução automática.

Versão original do texto

English

Tradução automática

Google Translator (abre serviço externo de tradução)
Microsoft Translator (abre serviço externo de tradução)

Como citar

Escolha um formato para exportar ou selecione um estilo de citação. O conteúdo abaixo pode ser atualizado após a seleção.

Baixar em RIS

Baixar em BIBTEX

Outros formatos de citação e exportação:

[TFN1] In general, the inclusions are ubiquitin-positive and contain the ubiquitin binding protein p62. (ALS: Amyotrophic Lateral Sclerosis; FTD: Frontotemporal dementia; UMN: upper motor neuron; bvFTD= behavioural Frontotemporal dementia)